Dedric Clarke, MD
Clinical Cardiac Electrophysiology · New Orleans, LANPI 1508056441
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Medtronic at 50.0% of the total. Reporting peaked in 2020 at $19,691 and has fallen 59.7% since, to $7,933 in 2025.
Across 423 payments — averaging $119.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$25K
- Abbott$13K
- Biotronik Inc.$6K
- Biosense Webster, Inc.$3K
- Irhythm Technologies, Inc.$648
- Novartis$457
- plus $3K from 28 others
What the payments were for
- Grants$29,00057%
- Travel & lodging$7,73215%
- Food & beverage$13,55727%
- Education$4631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 55 | $25,382 |
| Abbott | 110 | $12,606 |
| Biotronik Inc. | 24 | $5,564 |
| Biosense Webster, Inc. | 54 | $2,892 |
| Irhythm Technologies, Inc. | 30 | $648 |
| Novartis | 28 | $457 |
| Abiomed | 5 | $445 |
| Boston Scientific | 19 | $433 |
| AstraZeneca | 17 | $392 |
| Kestra Medical Technology Services, Inc. | 4 | $292 |
| E.r. Squibb & Sons, L.L.C. | 13 | $251 |
| Atricure, Inc. | 8 | $193 |
| Amgen | 7 | $187 |
| Impulse Dynamics (USA) Inc. | 3 | $138 |
| Johnson & Johnson | 8 | $132 |
| Novo Nordisk | 6 | $116 |
| Merck | 6 | $95 |
| Alnylam Pharmaceuticals Inc. | 3 | $86 |
| Lexicon Pharmaceuticals, Inc. | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $59 |
| Bayer | 2 | $42 |
| Baxter Healthcare | 1 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $23 |
| Stryker | 1 | $21 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
| Edwards Lifesciences | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Sandoz | 1 | $14 |
| Terumo Medical Corporation | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| United Therapeutics Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$1,552
- AVEIR$1,017
- AURORA EV-ICD MRI SURESCAN$286
- Micra$251
- Impella$234
- Amplia MRI$227
- HeartMate 3 Left Ventricular Dev$195
- CardioMEMS HF System$180
- Resolute$175
- Assure WCD$161
- Claria MRI$156
- NUVISION ICE CATHETER$139
- MyCareLink Smart$139
- Acticor$136
- Edora$136
- BioMonitor$136
- Solia$136
- Rivacor$136
- MyCareLink$132
- Assurity Pacemaker$129
How this compares
$50,752 in reported general payments places this provider in the 80th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 161 | $120,310 |
| XareltoRivaroxaban | 21 | $15,640 |
| EntrestoSacubitril/Valsartan | 12 | $15,248 |
| Propafenone Hcl ErPropafenone Hcl | 27 | $5,034 |
| Flecainide Acetate | 134 | $3,946 |
| Metoprolol Succinate | 154 | $1,766 |
| Bisoprolol Fumarate | 59 | $1,449 |
| Amiodarone Hcl | 12 | $554 |
| Fludrocortisone Acetate | 12 | $412 |
| Irbesartan | 13 | $372 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 11 | $326 |
| SotalolSotalol Hcl | 20 | $236 |
| Carvedilol | 28 | $152 |
| Amlodipine Besylate | 29 | $108 |
| Furosemide | 25 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $132 | $15,64021 claims |
| NovartisEntresto | $457 | $15,24812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in New Orleans
- Nassir MarroucheNew Orleans$498K
- Sammy KhatibNew Orleans$115K
- Paul LelorierNew Orleans$101K
- Adil YousufNew Orleans$101K
- Michael BernardNew Orleans$59K
- Glenn PolinNew Orleans$41K
- Colleen JohnsonNew Orleans$26K
- Omar KreidiehNew Orleans$26K
- Paul RogersNew Orleans$18K
- Freddy Abi-SamraNew Orleans$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.